PHCRF (Healius) Construction In Progress : $0 Mil (As of Dec. 2024)

View and export this data going back to 2014. Start your Free Trial

What is Healius Construction In Progress?

Healius's quarterly construction in progress increased from Dec. 2023 ($0 Mil) to Jun. 2024 ($5 Mil) but then declined from Jun. 2024 ($5 Mil) to Dec. 2024 ($0 Mil).

Healius's annual construction in progress declined from Jun. 2022 ($9 Mil) to Jun. 2023 ($6 Mil) and declined from Jun. 2023 ($6 Mil) to Jun. 2024 ($5 Mil).

Healius Construction In Progress Historical Data

The historical data trend for Healius's Construction In Progress can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Healius Construction In Progress Chart

Healius Annual Data

Trend

Jun15

Jun16

Jun17

Jun18

Jun19

Jun20

Jun21

Jun22

Jun23

Jun24

Construction In Progress

Get a 7-Day Free Trial

3.52

8.50

5.57

4.52

Healius Semi-Annual Data
	Jun15	Dec15	Jun16	Dec16	Jun17	Dec17	Jun18	Dec18	Jun19	Dec19	Jun20	Dec20	Jun21	Dec21	Jun22	Dec22	Jun23	Dec23	Jun24	Dec24
Construction In Progress	Get a 7-Day Free Trial															-	5.57	-	4.52	-

Healius Construction In Progress Calculation

It records the cost of construction work, which is not yet completed (typically, applied to capital budget items). A construction in progress item is not depreciated until the asset is placed in service. Normally, upon completion, a construction in progress item is reclassified, and the reclassified asset is capitalized and depreciated.

Healius Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Diagnostics & Research » Healius Ltd (OTCPK:PHCRF) » Definitions » Construction In Progress

Comparable Companies

Traded in Other Exchanges

PGZ:Germany HLS:Australia

Address

161 Castlereagh Street, Level 22, Sydney, NSW, AUS, 2000

Website

https://www.healius.com.au

Healius is Australia's second-largest pathology provider and third-largest diagnostic imaging provider, though the latter business is set to be sold in early 2025. Pathology and imaging revenue is almost entirely earned via the public health Medicare system. Healius typically earns approximately 75% of revenue from pathology and 25% from diagnostic imaging.